Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-3512676 + Radiation in Low-Grade B-Cell Lymphoma
NCT00880581Phase 2Completed
- Start
- Jan 2009
- Primary completion
- Sep 2011
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of agatolimod in B cell lymphoma. Started Jan 2009; status: completed.
02
Drugs
agatolimod
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT00880581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880581.